Trading Plan – Monday 23rd November 2020: First approval for Covid-19 treatment boosts equities

Mark NugentNov 2020, Trading Plan

Trading Plan – Monday 23rd November 2020: First approval for Covid-19 treatment boosts equities

The US FDA have given emergency use authorisation to Regeneron’s antibody cocktail therapy for Covid-19. This has generated positive risk sentiment and boosted equities and oil and pushed GOLD and JPY downwards, just as you would expect.

I think we may be entering a period of bullishness in the run up to Christmas as there will be multiple regulatory authorisations on both sides of the Atlantic over the next weeks. Further, actual vaccinations will begin, and a full re-opening of the global economy will seem significantly more tangible.

This has implications for assets that are particularly sensitive to sentiment (which is all of them, although some assets are more “cleanly” related to sentiment than others). This period of bullishness, if it happens and I think it is likely, offers significant opportunity for traders. I go through the detail of what to look for in the VIP Member’s video.

Happy trading. I’ll be back on Wednesday.

You can watch the video in the VIP Club members area HERE